- Main
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
- Adelstein, David;
- Gillison, Maura L;
- Pfister, David G;
- Spencer, Sharon;
- Adkins, Douglas;
- Brizel, David M;
- Burtness, Barbara;
- Busse, Paul M;
- Caudell, Jimmy J;
- Cmelak, Anthony J;
- Colevas, A Dimitrios;
- Eisele, David W;
- Fenton, Moon;
- Foote, Robert L;
- Gilbert, Jill;
- Haddad, Robert I;
- Hicks, Wesley L;
- Hitchcock, Ying J;
- Jimeno, Antonio;
- Leizman, Debra;
- Lydiatt, William M;
- Maghami, Ellie;
- Mell, Loren K;
- Mittal, Bharat B;
- Pinto, Harlan A;
- Ridge, John A;
- Rocco, James;
- Rodriguez, Cristina P;
- Shah, Jatin P;
- Weber, Randal S;
- Witek, Matthew;
- Worden, Frank;
- Yom, Sue S;
- Zhen, Weining;
- Burns, Jennifer L;
- Darlow, Susan D
- et al.
Published Web Location
https://doi.org/10.6004/jnccn.2017.0101Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-